James A McCormick Selected Research

James A McCormick Research Topics

Disease

25	Hypertension (High Blood Pressure) 04/2024 - 04/2011
3	Polyuria 11/2022 - 01/2016
3	Hyperkalemia 01/2022 - 11/2011
3	Gitelman Syndrome 12/2020 - 12/2013
3	Hypokalemia 12/2018 - 06/2017
2	Proteinuria 10/2021 - 01/2020
2	Inborn Genetic Diseases (Disease, Hereditary) 12/2020 - 10/2011
2	Inflammation (Inflammations) 01/2020 - 11/2014
2	Fibrosis (Cirrhosis) 01/2020 - 11/2014
2	Hypercalciuria 01/2019 - 11/2011
2	Alkalosis 01/2018 - 11/2014
2	Hypotension (Low Blood Pressure) 01/2016 - 11/2014
1	Cardiac Arrhythmias (Arrythmia) 01/2023
1	Liddle Syndrome 10/2022
1	Body Weight (Weight, Body) 01/2022
1	Rhabdomyolysis 10/2021
1	Albuminuria 01/2021
1	Heart Arrest (Cardiac Arrest) 01/2020
1	Necrosis 01/2020
1	Cardio-Renal Syndrome 01/2020
1	Atrophy 12/2018
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2016
1	Pseudohypoaldosteronism 01/2015
1	SeSAME syndrome 01/2015
1	Wasting Syndrome (Wasting Disease) 01/2015
1	Diabetes Insipidus 11/2014
1	Bartter Syndrome (Syndrome, Bartter) 12/2013
1	Insulin Resistance 12/2011
1	Autoimmune Diseases (Autoimmune Disease) 10/2011
1	Diabetes Mellitus 04/2011
1	Familial Hypophosphatemic Rickets (X-Linked Hypophosphatemia) 10/2010
1	Hypophosphatemia 10/2010

Drug/Important Bio-Agent (IBA)

8	SaltsIBA 01/2021 - 04/2011
7	Cullin Proteins (Cullins)IBA 01/2023 - 11/2014
7	Phosphotransferases (Kinase)IBA 10/2018 - 10/2011
6	Proteins (Proteins, Gene)FDA Link 01/2023 - 11/2014
5	UbiquitinIBA 10/2023 - 11/2014
5	PotassiumIBA 01/2023 - 01/2015
4	Ligases (Synthetase)IBA 10/2023 - 12/2017
4	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2023 - 01/2016
4	ThiazidesIBA 10/2018 - 11/2011
3	SodiumIBA 04/2024 - 05/2012
3	Aquaporin 2IBA 11/2022 - 11/2014
2	Cyclin EIBA 11/2022 - 11/2014
2	AldosteroneIBA 01/2022 - 01/2016
2	Sodium Chloride Symporter Inhibitors (Diuretics, Thiazide)IBA 12/2020 - 10/2011
2	Lysine (L-Lysine)FDA Link 10/2018 - 01/2016
2	Calcineurin InhibitorsIBA 05/2012 - 10/2011
2	Sodium Chloride SymportersIBA 11/2011 - 10/2011
1	Insulin (Novolin)FDA Link 01/2023
1	AcidsIBA 01/2023
1	Biomarkers (Surrogate Marker)IBA 11/2022
1	benzamilIBA 10/2022
1	Deamino Arginine Vasopressin (Desmopressin)FDA LinkGeneric 10/2022
1	Vasopressin Receptors (Arginine Vasopressin Receptor)IBA 10/2022
1	Mineralocorticoid Receptor AntagonistsIBA 01/2022
1	Eplerenone (Inspra)FDA LinkGeneric 01/2022
1	Glycerol (Glycerine)FDA LinkGeneric 10/2021
1	Low Density Lipoprotein Receptor-Related Protein-2IBA 10/2021
1	MyoglobinIBA 10/2021
1	Cilastatin FDA Link 10/2021
1	Saline SolutionIBA 10/2021
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2021
1	salicylhydroxamic acid (SHAM)IBA 01/2020
1	Fibrillin-1IBA 01/2020
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2020
1	Mutant Proteins (Protein, Mutant)IBA 01/2020
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 11/2019
1	Furosemide (Lasix)FDA LinkGeneric 01/2019
1	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 01/2019
1	CalciumIBA 01/2019
1	Dietary PotassiumIBA 12/2018
1	RNA (Ribonucleic Acid)IBA 01/2018
1	Angiotensin Receptor AntagonistsIBA 01/2018
1	Amlodipine (Norvasc)FDA LinkGeneric 01/2018
1	Losartan (Cozaar)FDA LinkGeneric 01/2018
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2018
1	thiazide receptorIBA 06/2017
1	Sodium-Potassium-Chloride SymportersIBA 11/2014
1	Sodium Chloride FDA LinkGeneric 07/2014
1	Alanine (L-Alanine)FDA Link 12/2013
1	Proline (L-Proline)FDA Link 12/2013
1	CationsIBA 12/2013
1	Member 3 Solute Carrier Family 12IBA 12/2013
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 05/2012
1	Glucose (Dextrose)FDA LinkGeneric 12/2011
1	ElectrolytesIBA 11/2011
1	DiureticsIBA 11/2011
1	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 10/2011
1	Tacrolimus (Prograf)FDA LinkGeneric 10/2011
1	Calcitriol (Calcijex)FDA LinkGeneric 10/2010
1	Phosphates (Orthophosphate)IBA 10/2010

Therapy/Procedure

2	Therapeutics 11/2011 - 10/2010
1	Sodium-Restricted Diet (Diet, Sodium Restricted) 01/2022
1	Cardiopulmonary Resuscitation (CPR) 01/2020
1	Injections 10/2010